Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial Pavel, M., Benavent, M., Perros, P., Srirajaskanthan, R., Warner, R. P., Kulke, M. H., Anthony, L. B., Kunz, P. L., Hoersch, D., Lapuerta, P., Fleming, R., Gross, D. J. LIPPINCOTT WILLIAMS & WILKINS. 2018: 350
View details for Web of Science ID 000426086300085